*/
Casey Randall explores the benefits of prenatal paternity testing and explains how the test is performed
A non-invasive prenatal paternity (NIPP) test is the safest option for anyone looking to establish paternity before a baby is born and can be extremely beneficial for legal purposes.
As the only testing laboratory in the UK to be UKAS-accredited for prenatal paternity testing, we are often asked about the circumstances in which prenatal paternity testing is most suitable for court proceedings. This includes:
While in the past the court would have been left in the dark about a child’s paternity until after birth, advances in DNA analysis mean that it is now possible to perform a NIPP test as early as seven weeks into pregnancy. Demand is on the rise as more people discover the benefits of this type of test. We have seen a 47% increase in consumer sales of prenatal paternity tests (2021) versus pre-pandemic levels (AlphaBiolabs DNA testing data (2019-2021)).
DNA samples required for a legally admissible prenatal paternity test must be collected under strict chain of custody conditions. This means that a trained sample collector will ensure samples are obtained correctly and from the right individuals, before they are safely transported back to the lab.
Unlike other types of prenatal paternity test that require cells to be taken from the placenta (chorionic villus sampling or CVS test) or a sample of amniotic fluid (amniocentesis), a NIPP test only requires a blood sample from the mother and cheek (buccal) DNA swabs from the mother and the alleged father. Therefore, a NIPP test – such as that offered by AlphaBiolabs – is 100% risk free for mother and baby.
To perform the test, a blood sample is collected from the mother by a trained medical professional such as a phlebotomist, nurse, or another medical practitioner, and promptly returned to the laboratory to be analysed. This reduces the likelihood of the blood degrading in transit, which can render a sample unusable.
Cheek (buccal) swabs can be collected from the mother and alleged father at a convenient time, and simply requires a swab to be rubbed quickly and painlessly on the inside of the cheek to collect DNA. Although the mother and alleged father’s samples do not need to be collected at the same location, it is advised that they are collected around the same time, to ensure testing can begin as soon as the mother’s blood sample is received.
Once the mother’s and alleged father’s samples have been received by the testing laboratory, DNA is extracted from both samples. The very latest scientific techniques ensure the baby’s DNA can be identified within the mother’s blood sample. Short tandem repeats (STRs) and single nucleotide polymorphisms (SNPs) are used to perform NIPP testing, with expert geneticists able to analyse the genetic markers in each DNA profile.
Every person inherits half of their DNA from their mother and half from their father. This means that the foetus will have two copies of each STR marker, known as alleles, in their DNA profile – one from each of the biological parents. By comparing the alleles at each marker with the DNA collected from the mother and the alleged father, geneticists can determine whether the man is the biological father of the baby; provided there is sufficient foetal DNA within the mother’s blood sample.
Prenatal paternity testing can provide the vital evidence needed for counsel to reach important decisions about a child’s future.
An AlphaBiolabs’ prenatal paternity test can be used to test more than one alleged father, with results available in four-to-seven days. A comprehensive statement of witness report is included as standard. Legal customers can also benefit from free sample collection at any of our 11 nationwide walk-in centres.
For expert advice on which drug test is best for your client, call the AlphaBiolabs Customer Services team on 0330 600 1300 or email testing@alphabiolabs.com and a member of the Legal Team will be in touch.
For further information please visit: https://www.alphabiolabs.co.uk
A non-invasive prenatal paternity (NIPP) test is the safest option for anyone looking to establish paternity before a baby is born and can be extremely beneficial for legal purposes.
As the only testing laboratory in the UK to be UKAS-accredited for prenatal paternity testing, we are often asked about the circumstances in which prenatal paternity testing is most suitable for court proceedings. This includes:
While in the past the court would have been left in the dark about a child’s paternity until after birth, advances in DNA analysis mean that it is now possible to perform a NIPP test as early as seven weeks into pregnancy. Demand is on the rise as more people discover the benefits of this type of test. We have seen a 47% increase in consumer sales of prenatal paternity tests (2021) versus pre-pandemic levels (AlphaBiolabs DNA testing data (2019-2021)).
DNA samples required for a legally admissible prenatal paternity test must be collected under strict chain of custody conditions. This means that a trained sample collector will ensure samples are obtained correctly and from the right individuals, before they are safely transported back to the lab.
Unlike other types of prenatal paternity test that require cells to be taken from the placenta (chorionic villus sampling or CVS test) or a sample of amniotic fluid (amniocentesis), a NIPP test only requires a blood sample from the mother and cheek (buccal) DNA swabs from the mother and the alleged father. Therefore, a NIPP test – such as that offered by AlphaBiolabs – is 100% risk free for mother and baby.
To perform the test, a blood sample is collected from the mother by a trained medical professional such as a phlebotomist, nurse, or another medical practitioner, and promptly returned to the laboratory to be analysed. This reduces the likelihood of the blood degrading in transit, which can render a sample unusable.
Cheek (buccal) swabs can be collected from the mother and alleged father at a convenient time, and simply requires a swab to be rubbed quickly and painlessly on the inside of the cheek to collect DNA. Although the mother and alleged father’s samples do not need to be collected at the same location, it is advised that they are collected around the same time, to ensure testing can begin as soon as the mother’s blood sample is received.
Once the mother’s and alleged father’s samples have been received by the testing laboratory, DNA is extracted from both samples. The very latest scientific techniques ensure the baby’s DNA can be identified within the mother’s blood sample. Short tandem repeats (STRs) and single nucleotide polymorphisms (SNPs) are used to perform NIPP testing, with expert geneticists able to analyse the genetic markers in each DNA profile.
Every person inherits half of their DNA from their mother and half from their father. This means that the foetus will have two copies of each STR marker, known as alleles, in their DNA profile – one from each of the biological parents. By comparing the alleles at each marker with the DNA collected from the mother and the alleged father, geneticists can determine whether the man is the biological father of the baby; provided there is sufficient foetal DNA within the mother’s blood sample.
Prenatal paternity testing can provide the vital evidence needed for counsel to reach important decisions about a child’s future.
An AlphaBiolabs’ prenatal paternity test can be used to test more than one alleged father, with results available in four-to-seven days. A comprehensive statement of witness report is included as standard. Legal customers can also benefit from free sample collection at any of our 11 nationwide walk-in centres.
For expert advice on which drug test is best for your client, call the AlphaBiolabs Customer Services team on 0330 600 1300 or email testing@alphabiolabs.com and a member of the Legal Team will be in touch.
For further information please visit: https://www.alphabiolabs.co.uk
Casey Randall explores the benefits of prenatal paternity testing and explains how the test is performed
The age of criminal responsibility, extreme weather and conflict resolution – plus, new protocol for reporting bullying at the Bar
By David Green
Mário Barroso, Head of R&D and Method Development at AlphaBiolabs, examines the forensic science underpinning hair drug testing, its evidential scope and limitations, and why it remains the gold standard for evidencing patterns of drug use in family proceedings
Unlocking your aged debt to fund your tax in one easy step. By Philip N Bristow
Clement Cowley, Partner at The Penny Group, discusses the upcoming changes to pensions and Inheritance Tax and the potential impact on your financial future
Save the Children UK is the latest charity to benefit from a £500 donation from AlphaBiolabs via the company’s Giving Back initiative
Barrister apprenticeships – shortly to provide the fourth pathway to the Bar – are an ideal opportunity to support local talent and ‘grow your own’, say Tim Coulson and Dr Jane Dennehy
Solicitor General Ellie Reeves KC MP discusses her decade as a trade union and employment law barrister, the demands of life as a Law Officer and the number one priority shaping her work. Interview by Anthony Inglese CB
A decade of reviews and research has disrupted accepted thinking in the search for causality. Suicides following abuse have overtaken domestic homicides. Is the law keeping up? Professor Susan Edwards KC (Hon) examines recent cases and the obstacles to successful prosecution
Why every major sporting event needs an anti-corruption policy. By Louis Weston
At least not that way, says Richard Paige
